MedTrace Logo

Sarcopenia in Head and Neck Cancer Patients Treated with Curative Hadrontherapy

NCT06207708 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-02-13

No results posted yet for this study

Summary

The study focuses on the impact of sarcopenia on acute and late toxicities in head and neck tumor affected patients treated with particle therapy.

Conditions

Interventions

OTHER

questionnaires QLQ-FA12, Mini Nutritional Assessment Short Form, Nutritional Risk Screening, diet questionnaire of frequency, ,body mass index measurement

the patient is administered with questionnaires focused on diet, fatigue, nutrition screening and on body mass index at the beginning and at the end pf particle therapy radiation treatment

DIAGNOSTIC_TEST

blood biomarkers

as per clinical routine, hemoglobin, lymphocytes, albumin and NLR will be collected

Sponsors & Collaborators

  • CNAO National Center of Oncological Hadrontherapy

    lead OTHER

Principal Investigators

  • Rossana Ingargiola, MD · CNAO National Center of Oncological Hadrontherapy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-18
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06207708 on ClinicalTrials.gov